Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study

被引：0
|
作者：
Mercedes P Jacobson
Ladislav Pazdera
Perminder Bhatia
Todd Grinnell
Hailong Cheng
David Blum
机构：
[1] Temple University School of Medicine,Department of Neurology
[2] CTC Rychnov nad Kněznou s.r.o,undefined
[3] Neuro-Pain Medical Center,undefined
[4] Sunovion Pharmaceuticals Inc.,undefined
来源：
BMC Neurology | / 15卷
关键词：
Antiepileptic; Eslicarbazepine acetate; Partial onset seizures; Epilepsy; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EFFICACY OF ESLICARBAZEPINE ACETATE VERSUS CONTROLLED-RELEASE CARBAMAZEPINE AS MONOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL-ONSET SEIZURES
    Ben-Menachem, E.
    Trinka, E.
    Kowacs, P.
    Elger, C.
    Moreira, J.
    Pinto, R.
    Ikedo, F.
    Pereira, A.
    Rocha, J. F.
    Soares-da-Silva, P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
  • [32] Assessment of Eslicarbazepine Acetate Monotherapy vs. Other Anti-Epileptic Drugs for Refractory Partial-Onset Seizures: Results of a Network Meta-Analysis Using Historical-Control Trials
    Velez, Fulton
    Grinnell, Todd
    Siddiqui, Mohd Kashif
    Blum, David
    NEUROLOGY, 2016, 86
  • [33] Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures
    Chung, Steve
    Sinha, Saurabh R.
    Shah, Aashit
    Stern, John M.
    Cheng, Hailong
    Jung, JungAh
    Grinnell, Todd
    Blum, David
    EPILEPSY RESEARCH, 2019, 153 : 59 - 65
  • [34] REAL-WORLD DATA ON ESLICARBAZEPINE ACETATE AS ADD-ON TREATMENT TO ANTIEPILEPTIC MONOTHERAPY IN ADULTS WITH PARTIAL-ONSET SEIZURES: THE EPOS STUDY
    Holtkamp, M.
    McMurray, R.
    Sousa, R.
    Kockelmann, E.
    EPILEPSIA, 2015, 56 : 59 - 60
  • [35] Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study
    Elger, Christian
    Halasz, Peter
    Maia, Joana
    Almeida, Luis
    Soares-da-Silva, Patricio
    EPILEPSIA, 2009, 50 (03) : 454 - 463
  • [36] Evaluation of Efficacy and Safety of Eslicarbazepine Acetate (ESL) as Add-On Treatment in Adults with Refractory Partial-Onset Seizures: BIA-2093-302 Study
    Ben-Menachem, Elinor
    Gabbai, Alberto A.
    Hufnage, Andreas
    Versave, Mark
    Maia, Joana
    Almeida, Luis
    Soares-da-Silva, Patricio
    ANNALS OF NEUROLOGY, 2009, 66 : S15 - S15
  • [37] EFFICACY OF ESLICARBAZEPINE ACETATE VS. CONTROLLED-RELEASE CARBAMAZEPINE AS MONOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL-ONSET SEIZURES
    Ben-Menachem, E.
    Trinka, E.
    Kowacs, P.
    Elger, C.
    Moreira, J.
    Pinto, R.
    Ikedo, F.
    Pereira, A.
    Rocha, J-F
    Soares-da-Silva, P.
    EPILEPSIA, 2016, 57 : 32 - 32
  • [38] Lacosamide - Efficacy and safety results in adults with partial-onset seizures
    Ben, Menachem E.
    EPILEPSIA, 2007, 48 : 176 - 176
  • [39] Effectiveness of eslicarbazepine acetate as add-on treatment to antiepileptic monotherapy in adults with partial-onset seizures (EPOS study): analysis by baseline antiepileptic drug
    Lawthom, C.
    McMurray, R.
    Sousa, R.
    Holtkamp, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 342 - 342
  • [40] Eslicarbazepine acetate as add-on treatment to antiepileptic monotherapy in adults with partial-onset seizures: real-world data from the EPOS study
    Holtkamp, M.
    McMurray, R.
    Sousa, R.
    Kockelmann, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 63 - 63
12345